FDA Inspection 1142734 — Stephen G. Slade, M.D.
The FDA completed an inspection of Stephen G. Slade, M.D. on May 7, 2021 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 7, 2021
- Fiscal Year
- 2021
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Houston, TX (United States)
Additional Details
Clinical Investigator (CI)